Literature DB >> 25288392

Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.

Susanna Ranta1, Ruta Tuckuviene, Anne Mäkipernaa, Birgitte K Albertsen, Tony Frisk, Ulf Tedgård, Ólafur G Jónsson, Kaie Pruunsild, Nadine Gretenkort Andersson, Maria Winther Gunnes, Sonata Saulyte Trakymiene, Thomas Frandsen, Mats Heyman, Ellen Ruud, Jon Helgestad.   

Abstract

We present a prospective multicentre cohort of 20 children with acute lymphoblastic leukaemia (ALL) and cerebral sinus venous thrombosis (CSVT). The study covers a period of 5 years and comprises 1038 children treated according to the Nordic Society of Paediatric Haematology and Oncology (NOPHO) ALL 2008 protocol. The cumulative incidence of CSVT was 2%. Sixteen of the thromboses were related to asparaginase and 16 to steroids. Most CSVTs occurred in the consolidation phase. Nearly all were treated with low molecular weight heparin without bleeding complications. Mortality related to CSVT directly or indirectly was 10%, emphasizing the importance of this complication.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute leukaemia; cerebral sinovenous thrombosis; paediatric

Mesh:

Substances:

Year:  2014        PMID: 25288392     DOI: 10.1111/bjh.13162

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

Review 1.  Neurological Complications of Pediatric Cancer.

Authors:  Elizabeth C Neil; Sharyu Hanmantgad; Yasmin Khakoo
Journal:  J Child Neurol       Date:  2015-12-29       Impact factor: 1.987

Review 2.  Cerebral Venous Thrombosis: an Update.

Authors:  José M Ferro; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

3.  Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Authors:  Sumit Gupta; Cindy Wang; Elizabeth A Raetz; Reuven Schore; Wanda L Salzer; Eric C Larsen; Kelly W Maloney; Len A Mattano; William L Carroll; Naomi J Winick; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas
Journal:  J Clin Oncol       Date:  2020-04-10       Impact factor: 44.544

Review 4.  Neurological Complications of the Leukemias Across the Ages.

Authors:  Stephanie Berg; Sucha Nand
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

Review 5.  Thrombosis in leukemia: incidence, causes, and practical management.

Authors:  Patricia Guzmán-Uribe; Ángel Gabriel Vargas-Ruíz
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

Review 6.  Neurologic Emergencies in the Patients With Cancer.

Authors:  Andrew L Lin; Edward K Avila
Journal:  J Intensive Care Med       Date:  2016-07-09       Impact factor: 3.510

7.  Cerebral sinovenous thrombosis in children: A single-center experience.

Authors:  İpek Dokurel Çetin; Cenk Eraslan; Erdem Şimşek; Seda Kanmaz; Hepsen Mine Serin; Deniz Yılmaz Karapınar; Sanem Keskin Yılmaz; Gül Aktan; Hasan Tekgül; Sarenur Gökben
Journal:  Turk Arch Pediatr       Date:  2021-05-01

8.  TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.

Authors:  Irene L M Klaassen; Mandy N Lauw; Marianne D van de Wetering; Bart J Biemond; Saskia Middeldorp; Floor C H Abbink; Marc Bierings; D Maroeska M W Te Loo; Rob Pieters; Inge M van der Sluis; Wim J E Tissing; C Michel Zwaan; C Heleen van Ommen
Journal:  BMC Pediatr       Date:  2017-05-10       Impact factor: 2.125

9.  A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.

Authors:  Saara Roininen; Outi Laine; Marjut Kauppila; Marko Vesanen; Maria Rämet; Marjatta Sinisalo; Esa Jantunen; Marjaana Säily; Riikka Räty; Erkki Elonen; Ulla Wartiovaara-Kautto
Journal:  Cancer Med       Date:  2017-05-15       Impact factor: 4.452

Review 10.  Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia.

Authors:  Jamie Koprivnikar; James McCloskey; Stefan Faderl
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.